Effect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine glioma
- 30 January 2014
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 61 (7) , 1180-1183
Abstract
Background: Children with diffuse intrinsic pontine glioma (DIPG) continue to have poor outcomes, and radiotherapy (RT) is the only temporarily effective treatment. In this retrospective analysis, we studied the effect of time from diagnosis to start of RT on event‐free survival (EFS) and overall survival (OS) in children with DIPG.Methods: Records of children (n = 95) with DIPG treated with RT at a single institution between April 1999 and September 2009 were analyzed. RT was delivered at doses of 54.0–55.8 Gy at 1.8 Gy per fraction, and children were followed prospectively. The effect of gender, race, interruption during treatment course, age at diagnosis, duration of symptoms prior to diagnosis, use of protocol‐based chemotherapy, and time from diagnosis to initiation of RT on EFS and OS was assessed by the Cox proportional hazards model.Results: Time as a continuous variable from diagnosis to start of RT did not affect outcome. Time dichotomized to ≤14 days significantly affected OS (hazard ratio [HR] = 1.70, P = 0.014) and race other than white or black affected EFS (HR = 2.32, P = 0.017). The 95 patients had a 6‐month EFS and OS of 60 ± 5% and 94.7 ± 2.3%, respectively, and a 12‐month EFS and OS of 11.6 ± 3.1% and 49.5 ± 5%, respectively.Conclusions: Time as a continuous variable did not affect OS or EFS in our cohort; however, children treated within 2 weeks of diagnosis had poor outcomes. Although rapid initiation of RT is desirable, our findings do not support intensive efforts aimed at shortening delays from diagnosis to start of RT. Pediatr Blood Cancer 2014;61:1180–1183.Keywords
Funding Information
- American Lebanese Syrian Associated Charities (ALSAC)
- National Institutes of Health (CA23099, CA21765)
This publication has 32 references indexed in Scilit:
- Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine gliomaJournal of Neuro-Oncology, 2013
- Diffuse intrinsic pontine glioma: poised for progressFrontiers in Oncology, 2012
- Dependence of intrafraction motion on fraction duration for pediatric patients with brain tumorsJournal of Applied Clinical Medical Physics, 2011
- Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology GroupNeuro-Oncology, 2011
- Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomasNeuro-Oncology, 2011
- Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine GliomaJournal of Clinical Oncology, 2010
- Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium StudyJournal of Clinical Oncology, 2010
- The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine gliomaJournal of Neuro-Oncology, 2010
- Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP‐16: A Children's Oncology Group phase II studyPediatric Blood & Cancer, 2007
- Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: A pediatric oncology group studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993